Estimation of skin dose rate from a catheter bag filled with P-32 solution

Nuclear Medicine Communications
Katrina C CockburnGraham A Wright

Abstract

Patients attending for therapy with phosphorus-32 (P-32) may have problems with urinary continence requiring the use of a urinary catheter. P-32 is excreted renally and the contents of the catheter bag will impart a dose to the skin with which the bag is in contact. We simulated a catheter bag filled with P-32-contaminated urine and measured the dose rate per unit activity from the bag. A volume of 25 MBq of P-32 was added to a 500 ml bag of saline and mixed thoroughly. A personal dosimetry badge was fixed to the surface of the bag and left for 48 h before being sent for processing. To account for decay, the cumulative activity in the bag over the 48 h period was calculated and the shallow [Hp(0.07)] dose measured by the badge was divided by the cumulative activity to yield a dose rate per MBq of activity. The measured Hp(0.07) dose was 192.8 mSv, which corresponds to a dose rate per MBq of 169 μSv/h/MBq. This study has shown that the dose rate per MBq from a simulated catheter bag of radioactive phosphorus differs from the dose rates published for other containers. This value may be useful in the risk assessment of P-32 therapy in catheterized patients.

References

Mar 28, 2002·Radiation Protection Dosimetry·D DelacroixC Hickman
Mar 31, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Jan Tennvall, Boudewijn Brans

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.